{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:10:12Z","timestamp":1761894612542},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.transci.2007.04.012","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T10:23:53Z","timestamp":1193135033000},"page":"31-35","source":"Crossref","is-referenced-by-count":5,"title":["The curability of follicular lymphoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Matthew","family":"Lunning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2007.04.012_bib1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The non-Hodgkin\u2019s Lymphoma Classification Project: a clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.transci.2007.04.012_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2007.04.012_bib3","series-title":"World Health Organization classification of tumors","article-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","year":"2001"},{"issue":"2","key":"10.1016\/j.transci.2007.04.012_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hon.2900010209","article-title":"Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method","volume":"1","author":"Mann","year":"1983","journal-title":"Hematol Oncol"},{"issue":"23","key":"10.1016\/j.transci.2007.04.012_bib5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.transci.2007.04.012_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","article-title":"Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center","volume":"13","author":"Johnson","year":"1995","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.transci.2007.04.012_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1200\/JCO.1985.3.3.299","article-title":"Karnofsky memorial lecture. The low-grade non-Hodgkin\u2019s lymphomas: challenges and opportunities","volume":"3","author":"Rosenberg","year":"1985","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.transci.2007.04.012_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1993.11.4.644","article-title":"Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy","volume":"11","author":"Dana","year":"1993","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.transci.2007.04.012_bib9","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1182\/blood-2001-12-0269","article-title":"Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma","volume":"100","author":"Tsimberidou","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.transci.2007.04.012_bib10","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.transci.2007.04.012_bib11","doi-asserted-by":"crossref","first-page":"147a","DOI":"10.1182\/blood.V108.11.486.486","article-title":"Single treatment with rituximab monotherapy for low-tumor burden follicular lymhoma (FL): survival analyses with extended follow-up (F\/Up) of 7 years","volume":"108","author":"Colombat","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2007.04.012_bib12","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2007.04.012_bib13","doi-asserted-by":"crossref","first-page":"146a","DOI":"10.1182\/blood.V108.11.481.481","article-title":"MabThera(Rituximab) plus cyclophosphamide, vincristine and prednisone (CVP) chemotherapy improves survival in previously untreated patients with advanced follicular non-Hodgkin\u2019s lymphoma (NHL)","volume":"108","author":"Marcus","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2007.04.012_bib14","doi-asserted-by":"crossref","first-page":"146a","DOI":"10.1182\/blood.V108.11.482.482","volume":"108","author":"Buske","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2007.04.012_bib15","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","article-title":"Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly\u00d74 schedule","volume":"103","author":"Ghielmini","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2007.04.012_bib16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.2005.12.191","article-title":"Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin\u2019s lymphoma \u2013 a randomized phase II trial of the Minnie Pearl Cancer Research Network","volume":"23","author":"Hainsworth","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.transci.2007.04.012_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0093-7754(03)00237-9","article-title":"Radioimmunotherapy for non-Hodgkin\u2019s lymphoma","volume":"30","author":"Emmanouilides","year":"2003","journal-title":"Semin Oncol"},{"issue":"25","key":"10.1016\/j.transci.2007.04.012_bib18","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2006.05.8198","article-title":"Phase II trial of CHOP chemotherapy followed by tositumomab\/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin\u2019s lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911","volume":"24","author":"Press","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.transci.2007.04.012_bib19","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood.V91.8.2955.2955_2955_2960","article-title":"The clinical significance of molecular response in indolent follicular lymphomas","volume":"91","author":"Lopez-Guillermo","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2007.04.012_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","article-title":"Frequency of the Bcl-2\/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma","volume":"19","author":"Summers","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.transci.2007.04.012_bib21","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","article-title":"Quantitative PCR of bone marrow BCL2\/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma","volume":"105","author":"Rambaldi","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2007.04.012_bib22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.pas.0000172191.87176.3b","article-title":"Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features","volume":"29","author":"Wang","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.transci.2007.04.012_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading","volume":"17","author":"Wohrer","year":"2006","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.transci.2007.04.012_bib24","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.transci.2007.04.012_bib25","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.1994.12.7.1349","article-title":"Follicular large-cell lymphoma: intermediate or low grade?","volume":"12","author":"Bartlett","year":"1994","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.transci.2007.04.012_bib26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1200\/JCO.1997.15.4.1654","article-title":"Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"15","author":"Wendum","year":"1997","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.transci.2007.04.012_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood.V56.1.98.98","article-title":"Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival","volume":"56","author":"Osborne","year":"1980","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.transci.2007.04.012_bib28","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood.V93.7.2202","article-title":"Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features","volume":"93","author":"Rodriguez","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2007.04.012_bib29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0889-8588(05)70468-8","article-title":"Follicular lymphomas: do histologic subtypes predict outcome?","volume":"11","author":"Miller","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.transci.2007.04.012_bib30","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdl039","article-title":"Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience","volume":"17","author":"Ganti","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.transci.2007.04.012_bib31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"Mac Manus","year":"1996","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.transci.2007.04.012_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(01)01747-3","article-title":"Long-term results with radiotherapy for Stage I\u2013II follicular lymphomas","volume":"51","author":"Wilder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.transci.2007.04.012_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hon.743","article-title":"Radiation therapy for localized low-grade non-Hodgkin\u2019s lymphomas","volume":"23","author":"Tsang","year":"2005","journal-title":"Hematol Oncol"},{"issue":"11","key":"10.1016\/j.transci.2007.04.012_bib34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.2003.07.111","article-title":"Long-term follow-up of a prospective study of combined modality therapy for stage I\u2013II indolent non-Hodgkin\u2019s lymphoma","volume":"21","author":"Seymour","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.transci.2007.04.012_bib35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdf198","article-title":"Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin\u2019s lymphoma registry","volume":"13","author":"Maartense","year":"2002","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.transci.2007.04.012_bib36","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","article-title":"Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group","volume":"104","author":"Lenz","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2007.04.012_bib37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1023\/A:1008399623564","article-title":"High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol","volume":"11","author":"Brice","year":"2000","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1016\/j.transci.2007.04.012_bib38","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin\u2019s lymphoma: results from the randomized European CUP trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.transci.2007.04.012_bib39","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","article-title":"Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma","volume":"12","author":"Rohatiner","year":"1994","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.transci.2007.04.012_bib40","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.transci.2007.04.012_bib41","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","article-title":"Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma","volume":"102","author":"van Besien","year":"2003","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.transci.2007.04.012_bib42","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","article-title":"Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality","volume":"98","author":"Khouri","year":"2001","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050207000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050207000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T09:57:04Z","timestamp":1587981424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050207000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1473050207000924"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2007.04.012","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}